Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows
No improvements in CD4 count at diagnosis in African patients in last decade
Starting HIV treatment early and then interrupting is no better than delaying it
Elite controllers may pay a high price for their low viral load
Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France
What are the barriers that could stop HIV treatment becoming HIV prevention?
Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up
Doravirine works as well as efavirenz with fewer CNS side-effects
